SCHEDULE 13G

Company

TG THERAPEUTICS, INC.

Filed

January 2, 2020

Accession Number

0001172661-20-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →